Diagnostic Radiopharmaceuticals and Contrast Media Market 2018 by Product Type, Top Manufacturers, Production, Revenue, Market Share, and Forecast

By , in Business on .

Diagnostic Radiopharmaceuticals & Contrast Media

Diagnostic Radiopharmaceuticals & Contrast Media Market covers worldwide information and accurate data about Diagnostic Radiopharmaceuticals & Contrast Media Industry, with a complete study of market-based on market drivers, market challenges, future trends. Diagnostic Radiopharmaceuticals & Contrast Media market also provides analysis by type, application, regions, manufacturers, technology, new entrants, raw materials analysis, manufacturing process.

Global Diagnostic Radiopharmaceuticals & Contrast Media market is projected to reach a CAGR of 9% between 2018 and 2023.

Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in at https://www.absolutereports.com/13103242

Top Manufacturers in Diagnostic Radiopharmaceuticals & Contrast Media Market: – Bayer Healthcare, GE Healthcare Guerbet Group, Bracco Imaging S.p.A, Mallinckrodt PLC, Lantheus Holdings, Inc., Amag Pharmaceuticals, Inc., Medtronic, Nordion, Inc. and many more.

Diagnostic Radiopharmaceuticals & Contrast Media Market Dynamics

  • Drivers
    – Technology Advancements in Medical Imaging
    – Increasing Demand for Image Guided Procedures and Diagnostics
    – High Prevalence of Cancers and Cardiac Diseases
  • Restraints
    – High Costs of the Techniques- Not Easily Affordable
    – Limited Health Insurance Coverage
    – Short Half-life of Radiopharmaceuticals
  • Market Opportunities
  • Key Challenges

    Key Developments in the Diagnostic Radiopharmaceuticals & Contrast Media Market:

  • January 2018: Guerbet has acquired the Accurate Medical Therapeutics. The acquisition will fuel Guerbets growth in interventional radiology and strengthen its current portfolio
  • March 2017: GE Healthcare expanded the MRI contrast media product range in Europe with macrocyclic agent Clariscan

    Ask for Sample PDF of Report at https://www.absolutereports.com/enquiry/request-sample/13103242

    Geographical Regions: – US, Canada, Mexico, France, UK, Germany, Italy, Spain, China, Japan, India, Australia & New Zealand, South Korea, GCC, South Africa, Brazil, Argentina

    Reasons to Purchase Diagnostic Radiopharmaceuticals & Contrast Media Market Report Covered:

    • The report examines how Diagnostic Radiopharmaceuticals & Contrast Media market will develop in the future.
    • Studying various views of the Diagnostic Radiopharmaceuticals & Contrast Media market with the help of Porter’s five forces analysis.
    • Analyzing the product type that is probably to control the market and regions that are likely to witness the fastest development during the forecast period
    • Identify the new developments, Diagnostic Radiopharmaceuticals & Contrast Media market shares and strategies employed by the key market players.
    • Competitive landscape including the market share of major players along with the key strategies accepted for growth in the past five years
    • Complete company profiles covering the product offerings, key financial information, current developments, SWOT analysis and strategies employed by the major Diagnostic Radiopharmaceuticals & Contrast Media market players

    Price of Report: $ 4250 (Single User Licence)

    Purchase Market Report at https://www.absolutereports.com/purchase/13103242

    Diagnostic Radiopharmaceuticals & Contrast Media Market drives a strong trend of R&D investments in this industry. Other growth drivers include the need to curtail costs, growth and increased use of shifting commodity prices, the strength of private label brands and increased competition from players in Diagnostic Radiopharmaceuticals & Contrast Media market.